161 related articles for article (PubMed ID: 38622522)
21. S100A9 as a novel diagnostic and prognostic biomarker in human gastric cancer.
Zhao Z; Zhang C; Zhao Q
Scand J Gastroenterol; 2020 Mar; 55(3):338-346. PubMed ID: 32172630
[No Abstract] [Full Text] [Related]
22. Bioinformatic analysis of hub markers and immune cell infiltration characteristics of gastric cancer.
Li C; Yang T; Yuan Y; Wen R; Yu H
Front Immunol; 2023; 14():1202529. PubMed ID: 37359529
[TBL] [Abstract][Full Text] [Related]
23. Flap endonuclease 1 (FEN1) as a novel diagnostic and prognostic biomarker for gastric cancer.
Zhao E; Zhou C; Chen S
Clin Res Hepatol Gastroenterol; 2021 Jan; 45(1):101455. PubMed ID: 32505732
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive Analysis of lncRNAs Associated with the Pathogenesis and Prognosis of Gastric Cancer.
Zhang X; Jiang Y; Xie Y; Leng X; Song F
DNA Cell Biol; 2020 Feb; 39(2):299-309. PubMed ID: 31934786
[TBL] [Abstract][Full Text] [Related]
25. Identification of diagnostic utility and molecular mechanisms of circulating miR-551b-5p in gastric cancer.
Jiang X; Jiang M; Xu M; Xu J; Li Y
Pathol Res Pract; 2019 May; 215(5):900-904. PubMed ID: 30732916
[TBL] [Abstract][Full Text] [Related]
26. CRNDE-h transcript/miR-136-5p axis regulates interleukin enhancer binding factor 2 expression to promote hepatocellular carcinoma cell proliferation.
Shiu TY; Lin HH; Shih YL; Feng AC; Huang HH; Huang TY; Hsieh CB; Chang WK; Hsieh TY
Life Sci; 2021 Nov; 284():119708. PubMed ID: 34153299
[TBL] [Abstract][Full Text] [Related]
27. Identification of biomarkers for diagnosis of gastric cancer by bioinformatics.
Wang DG; Chen G; Wen XY; Wang D; Cheng ZH; Sun SQ
Asian Pac J Cancer Prev; 2015; 16(4):1361-5. PubMed ID: 25743799
[TBL] [Abstract][Full Text] [Related]
28. Integrative analysis of epigenomics, transcriptomics, and proteomics to identify key targets and pathways of Weining granule for gastric cancer.
Liang MK; Liang XQ; Zhong J; Wei YT; Lian ZP; Huang ZK; Liang J
J Ethnopharmacol; 2021 Apr; 270():113787. PubMed ID: 33422657
[TBL] [Abstract][Full Text] [Related]
29. Identification of functional lncRNAs in gastric cancer by integrative analysis of GEO and TCGA data.
Zhang X; Zhang W; Jiang Y; Liu K; Ran L; Song F
J Cell Biochem; 2019 Oct; 120(10):17898-17911. PubMed ID: 31135068
[TBL] [Abstract][Full Text] [Related]
30. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
31. Tissue-based metabolomics reveals metabolic signatures and major metabolic pathways of gastric cancer with help of transcriptomic data from TCGA.
Wang Y; Chen W; Li K; Wu G; Zhang W; Ma P; Feng S
Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34549263
[TBL] [Abstract][Full Text] [Related]
32. Identification of hub genes and construction of an mRNA-miRNA-lncRNA network of gastric carcinoma using integrated bioinformatics analysis.
Wei G; Dong Y; He Z; Qiu H; Wu Y; Chen Y
PLoS One; 2021; 16(12):e0261728. PubMed ID: 34968391
[TBL] [Abstract][Full Text] [Related]
33. Upregulated circRNA_102231 promotes gastric cancer progression and its clinical significance.
Yuan G; Ding W; Sun B; Zhu L; Gao Y; Chen L
Bioengineered; 2021 Dec; 12(1):4936-4945. PubMed ID: 34374630
[TBL] [Abstract][Full Text] [Related]
34. Serum miR-515-3p, a potential new RNA biomarker, is involved in gastric carcinoma.
Han X; Li X; Zhao H; Zhou D; Sun B; Liu A; Zhang J; Cui Z; Ma X; Yuan L
J Cell Biochem; 2019 Sep; 120(9):15834-15843. PubMed ID: 31081157
[TBL] [Abstract][Full Text] [Related]
35. Microarray profile analysis identifies ETS1 as potential biomarker regulated by miR-23b and modulates TCF4 in gastric cancer.
Mei D; Qi Y; Xia Y; Ma J; Hu H; Ai J; Chen L; Wu N; Liao D
World J Surg Oncol; 2021 Oct; 19(1):311. PubMed ID: 34686186
[TBL] [Abstract][Full Text] [Related]
36. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
37. Identification of ALDH3A2 as a novel prognostic biomarker in gastric adenocarcinoma using integrated bioinformatics analysis.
Yin Z; Wu D; Shi J; Wei X; Jin N; Lu X; Ren X
BMC Cancer; 2020 Nov; 20(1):1062. PubMed ID: 33148208
[TBL] [Abstract][Full Text] [Related]
38. Exosomal miR-1246 in serum as a potential biomarker for early diagnosis of gastric cancer.
Shi Y; Wang Z; Zhu X; Chen L; Ma Y; Wang J; Yang X; Liu Z
Int J Clin Oncol; 2020 Jan; 25(1):89-99. PubMed ID: 31506750
[TBL] [Abstract][Full Text] [Related]
39. A panel of collagen genes are associated with prognosis of patients with gastric cancer and regulated by microRNA-29c-3p: an integrated bioinformatics analysis and experimental validation.
Zhang QN; Zhu HL; Xia MT; Liao J; Huang XT; Xiao JW; Yuan C
Cancer Manag Res; 2019; 11():4757-4772. PubMed ID: 31213898
[No Abstract] [Full Text] [Related]
40. THBS4 predicts poor outcomes and promotes proliferation and metastasis in gastric cancer.
Chen X; Huang Y; Wang Y; Wu Q; Hong S; Huang Z
J Physiol Biochem; 2019 Feb; 75(1):117-123. PubMed ID: 30746617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
